Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort study

Area of Science:

• Neonatal neurology
• Pediatric neurology
• Neurodevelopmental disorders

Background:

• Kernicterus spectrum disorder (KSD) is a significant cause of cerebral palsy globally, stemming from neonatal hyperbilirubinemia.
• Early identification of predictive clinical measures for KSD is crucial for timely intervention.

Purpose of the Study:

• To prospectively evaluate clinical measures for predicting KSD in neonates with hyperbilirubinemia.
• To determine the reliability of brain MRI, TSB, BIND-M, BAD, ABR, and HIRT in predicting KSD outcomes.

Main Methods:

• A 12-month prospective cohort study of neonates (≥35 weeks gestation, TSB ≥20 mg/dl) with hyperbilirubinemia.
• Clinical assessments included brain MRI (using HIRT), TSB, modified Bilirubin-Induced Neurologic Dysfunction (BIND-M), Barry-Albright Dystonia (BAD) scale, and auditory brainstem response (ABR).

Main Results:

• Of 25 neonates, 6 developed KSD. Neonatal BIND-M ≥3 showed 100% sensitivity and 83% specificity for KSD.
• Neonatal MRI (HIRT score 2) had 67% sensitivity and 75% specificity, improving to 100% at 12 months. BAD ≥2 was 100% specific for KSD from 3-12 months.

Conclusions:

• Neonatal brain MRI is not a reliable predictor of KSD.
• The modified BIND-M scale is a valuable screening tool for KSD risk.
• The BAD scale or HIRT score at 3 or 12 months can confirm KSD, enabling early diagnosis and intervention.